The following provides some further details of the comparisons of the fit to observed data of the original model of HIV progression and the effect of ART. This original model was used to provide the part of the model relating to prognosis and the effect of ART.
model --------------------------------------------------------------------------------------------------------------------------------------

-----------------------------------------------------------------------------------------------------------------------------------------
. Viral load set point and initial CD4 count (after primary infection) Table 3 . Incubation period AIDS to death (pre-ART era)
17 mths 15 mths Table 4 . Association between viral load measured close to seroconversion (between 6-24 months) and risk of AIDS, adjusting for CD4 count and age. Observed data from ref
5.
Adjusted Relative Hazard Table 5 . Risk of AIDS by CD4 count and viral load and age over 6 years (pre-HAART) 
values used in MACS may need to be multiplied by ~ 2 to approximate to more commonly used Roche assay levels. Table 6 . Median CD4 count at diagnosis of AIDS and at death (pre-HAART era) Table 7 . 3 year percent risk of AIDS after start of ART by baseline CD4 / viral load (age < 50, non-IDU, AIDS-free) ------------------------------------------------------------------------------------------------------------------------------------- --*Observed data may be overestimates due to some unrecognised stopping of ART Table 10 . Rate of viral rebound in people on 1st line HAART and with viral load < 50 copies/mL Table 11 . Median CD4 count change at 3 years from start of HAART 
mod ----------------------------------------------------------------------------------------------32% 32%
42% 46% 49% 51% 56% 56% --------------------------------------------------------------------------30% 32% 45% 47% 62% 59% 73% 67%  ------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------ 
59% 59% ----------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------- 1% 0% 3% 1% 4% 3% 7% 6% 9% 8% 12% 10% -
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model ----------------------------------------------------------------------------------------------------------- median (IQR) viral load15% 22% --------------------------------------------------------------------------------------------------------------- 4% 12% 7% 16% 10% 19% 12% 21% 14% 22% 16% 24% 19% 25% ---------------------------------------------------------------------------------------------------------------------- 1.0% 0.6% 2.7% 3.0% 4.1% 5.7% -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- M184V mutation 6% 10% 13% 14% 18% 17% (in) -------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------5%
9% 10% 17% 15% 24% 21%
27% --------------------------------------------------------------------------------------------------------------
